Carlos Orantes
Directeur Général chez Alcanza Clinical Research LLC
Profil
Carlos E.
Orantes is currently the Chief Executive Officer & Director at AMPLIFY Clinical, Inc. He is also the Chief Executive Officer at Alcanza Clinical Research LLC, the Head-Operations & Management at ALCANZA Consulting Partners LLC, and the President & Co-Chief Diversity Officer at hyperCORE International LLP.
Previously, Mr. Orantes held the position of Chief Executive Officer at Clinical Research Investments LLC and Accel Clinical Services LLC from 2015 to 2019.
He also served as the Director at Tech Council of Maryland, Inc., Vice President-Operations at Bridge Pharmaceuticals, Inc., Chief Operating Officer at Frontage Laboratories, Inc., and Executive Vice President at Avanza Laboratories LLC.
Mr. Orantes completed his undergraduate degree at George Washington University and holds an MBA from Old Dominion University.
Postes actifs de Carlos Orantes
| Sociétés | Poste | Début |
|---|---|---|
| ALCANZA Consulting Partners LLC | Directeur des opérations | - |
AMPLIFY Clinical, Inc.
 AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | Directeur Général | - |
Alcanza Clinical Research LLC
 Alcanza Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a company that operates as an integrated network of research facilities. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022. | Directeur Général | 01/01/2022 |
hyperCORE International LLP
 hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | President | 04/04/2023 |
Anciens postes connus de Carlos Orantes
| Sociétés | Poste | Fin |
|---|---|---|
Accel Clinical Services LLC
 Accel Clinical Services LLC BiotechnologyHealth Technology Accel Clinical Services LLC provides clinical research services. It offers clinical trials in a wide range of therapeutic indications to pharmaceuticals, biotech start-ups, and contract research organizations. It conducts Phase I, In-Hospital, vaccine and outpatient Phase II-IV trials. The company was founded in 1998 and is headquartered in DeLand, FL. | Directeur Général | 10/05/2019 |
Clinical Research Investments LLC
 Clinical Research Investments LLC Miscellaneous Commercial ServicesCommercial Services Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL. | Directeur Général | 01/04/2019 |
Avanza Laboratories LLC
 Avanza Laboratories LLC Miscellaneous Commercial ServicesCommercial Services Avanza Laboratories LLC provides pharmaceutical and agrochemical support. The company is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Frontage Laboratories, Inc.
 Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Directeur des opérations | - |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | - |
Formation de Carlos Orantes
| Old Dominion University | Masters Business Admin |
| George Washington University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Commercial Services |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
| ALCANZA Consulting Partners LLC | |
Frontage Laboratories, Inc.
Frontage Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA. | Commercial Services |
Accel Clinical Services LLC
Accel Clinical Services LLC BiotechnologyHealth Technology Accel Clinical Services LLC provides clinical research services. It offers clinical trials in a wide range of therapeutic indications to pharmaceuticals, biotech start-ups, and contract research organizations. It conducts Phase I, In-Hospital, vaccine and outpatient Phase II-IV trials. The company was founded in 1998 and is headquartered in DeLand, FL. | Health Technology |
Clinical Research Investments LLC
Clinical Research Investments LLC Miscellaneous Commercial ServicesCommercial Services Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL. | Commercial Services |
Avanza Laboratories LLC
Avanza Laboratories LLC Miscellaneous Commercial ServicesCommercial Services Avanza Laboratories LLC provides pharmaceutical and agrochemical support. The company is headquartered in Gaithersburg, MD. | Commercial Services |
AMPLIFY Clinical, Inc.
AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | Commercial Services |
Alcanza Clinical Research LLC
Alcanza Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a company that operates as an integrated network of research facilities. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022. | Commercial Services |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | Commercial Services |
